Sharaf El Din UAA - Search Results

1

Uric acid in the pathogenesis of metabolic, renal, and cardiovascular diseases: A review.

Sharaf El Din UAA, Salem MM, Abdulazim DO. Sharaf El Din UAA, et al. J Adv Res. 2017 Sep;8(5):537-548. doi: 10.1016/j.jare.2016.11.004. Epub 2016 Dec 3. J Adv Res. 2017. PMID: 28748119 Free PMC article. Review.

2

Diabetic nephropathy: Time to withhold development and progression - A review.

Sharaf El Din UAA, Salem MM, Abdulazim DO. Sharaf El Din UAA, et al. J Adv Res. 2017 Jul;8(4):363-373. doi: 10.1016/j.jare.2017.04.004. Epub 2017 Apr 21. J Adv Res. 2017. PMID: 28540086 Free PMC article. Review.

3

FGF23 and inflammation.

Sharaf El Din UA, Salem MM, Abdulazim DO. Sharaf El Din UA, et al. World J Nephrol. 2017 Jan 6;6(1):57-58. doi: 10.5527/wjn.v6.i1.57. World J Nephrol. 2017. PMID: 28101453 Free PMC article.

4

Fibroblast growth factor-23 is a strong predictor of insulin resistance among chronic kidney disease patients.

Fayed A, El Nokeety MM, Heikal AA, Abdulazim DO, Naguib MM, Sharaf El Din UAA; Vascular Calcification Group (VCG). Fayed A, et al. Among authors: sharaf el din uaa. Ren Fail. 2018 Nov;40(1):226-230. doi: 10.1080/0886022X.2018.1455594. Ren Fail. 2018. PMID: 29619868 Free PMC article.

5

Fibroblast growth factor-23 (FGF-23) is independently correlated to aortic calcification in haemodialysis patients.

Nasrallah MM, El-Shehaby AR, Salem MM, Osman NA, El Sheikh E, Sharaf El Din UA. Nasrallah MM, et al. Nephrol Dial Transplant. 2010 Aug;25(8):2679-85. doi: 10.1093/ndt/gfq089. Epub 2010 Feb 22. Nephrol Dial Transplant. 2010. PMID: 20176609

6

The Association between Fibroblast Growth Factor-23 and Vascular Calcification Is Mitigated by Inflammation Markers.

Nasrallah MM, El-Shehaby AR, Osman NA, Fayad T, Nassef A, Salem MM, Sharaf El Din UA. Nasrallah MM, et al. Nephron Extra. 2013 Nov 6;3(1):106-112. doi: 10.1159/000356118. eCollection 2013. Nephron Extra. 2013. PMID: 24348506 Free PMC article.

7

Vitamin D deficiency: an unrecognized cause of flank pain.

Abdulazim DO, Salem MM, Hassan M, Abdo A, Rashad E, Sharaf El Din UAA. Abdulazim DO, et al. Among authors: sharaf el din uaa. J Bone Miner Metab. 2018 Sep;36(5):605-608. doi: 10.1007/s00774-017-0874-z. Epub 2017 Nov 9. J Bone Miner Metab. 2018. PMID: 29124435

8

Sodium-glucose cotransporter 2 inhibitors as the first universal treatment of chronic kidney disease.

Sharaf El Din UAA, Salem MM, Abdulazim DO. Sharaf El Din UAA, et al. Nefrologia (Engl Ed). 2022 Jul-Aug;42(4):390-403. doi: 10.1016/j.nefroe.2022.08.001. Nefrologia (Engl Ed). 2022. PMID: 36460429 Free article. Review.

9

Sodium-glucose cotransporter 2 inhibitors as the first universal treatment of chronic kidney disease.

Sharaf El Din UAA, Salem MM, Abdulazim DO. Sharaf El Din UAA, et al. Nefrologia (Engl Ed). 2021 Aug 24:S0211-6995(21)00143-0. doi: 10.1016/j.nefro.2021.03.014. Online ahead of print. Nefrologia (Engl Ed). 2021. PMID: 34452776 Free article. Review. English, Spanish.

10

Vascular calcification: When should we interfere in chronic kidney disease patients and how?

Sharaf El Din UA, Salem MM, Abdulazim DO. Sharaf El Din UA, et al. World J Nephrol. 2016 Sep 6;5(5):398-417. doi: 10.5527/wjn.v5.i5.398. World J Nephrol. 2016. PMID: 27648404 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

11 results

Search Page